The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...
News Medical on MSN
Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
Patients with multiple CALMs w/wo skinfold freckling and no other typical NF1 associated features (Lisch nodules, bone abnormalities, neurofibromas, optic pathway gliomas). The DNA-based ...
Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback